ValGenesis, Inc., the global leader in digital validation lifecycle management, announced a strategic partnership with CAI, a professional services firm specializing in accelerating operational readiness in mission-critical environments, to expand the use of artificial intelligence (AI) in life sciences validation.
Through the partnership, CAI will deliver implementation services for ValGenesis’...
Quiver Bioscience, a discovery technology and therapeutics company advancing programs for treatment of serious central nervous system (CNS) disorders and chronic pain, announced receipt of a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). The Phase II grant, awarded by the National Institute of...
CIAI announced the launch of ciATHENA, a next generation Agentic AI platform built to accelerate commercial analytics across life sciences organizations. Combining natural language interfaces with intelligent agents, ciATHENA empowers various commercial teams to ask questions "Why am I seeing a trend break in new therapy starts this week?" or...
Powered by Causal AI and Real-Time Patient-Level Data and Analytics, the ClinOps Platform Enables Faster and Smarter Decision Making Across Trial Lifecycles
PhaseV, a leader in AI/ML-driven clinical development, announced the launch of the ClinOps platform, a next-generation solution designed to modernize clinical trial operations through precision-guided site selection and...
Danaher Corporation, a leading global life sciences and diagnostics innovator, announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer.
This appointment marks a pivotal step in Danaher's digital transformation and its ambition to lead...
Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, announced a strategic collaboration with AiCella, a company focused on harnessing the power of artificial intelligence (AI) to optimize the development of cell therapy production processes and maximize patient response...
New Pipeline Graph unifies competitive insights with preclinical research on a single AI platform to accelerate drug target identification and increase commercial success
Causaly announced Pipeline Graph, giving life sciences research and development teams a more effective and efficient way to do competitive intelligence earlier in drug discovery. The AI-powered application...
Circulogene, a leading provider of precision diagnostics for lung cancer, has announced the national commercial launch of LungLifeAI, now available across its expanding base of primary care clients.
LungLifeAI is an AI-powered blood test that supports early lung cancer detection by helping physicians assess malignancy risk in indeterminate pulmonary nodules (IPNs)...
Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, announced the successful mapping of conserved therapeutic targets within the measles virus (MeV) genome using BioSeeker™, the company’s proprietary AI-powered discovery engine. Amid rising measles outbreaks worldwide, this breakthrough marks a...
SandboxAQ announced the launch of SAIR (Structurally Augmented IC50 Repository), the largest-ever detailed dataset of protein-ligand pairs with annotated experimental potency data. Marking a major milestone in computational drug discovery, SAIR provides an unprecedented resource for researchers to advance AI models in drug discovery, significantly enhancing the speed and...
